Hasil Pencarian - David S. Hong

Perbaiki Hasil
  1. 1
    KRAS G12C inhibitor combination therapies: current evidence and challenge

    KRAS G12C inhibitor combination therapies: current evidence and challenge oleh Hirotaka Miyashita, Shumei Kato, David S. Hong

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Targeting KRAS: Crossroads of Signaling and Immune Inhibition

    Targeting KRAS: Crossroads of Signaling and Immune Inhibition oleh Shumei Kato, Yu Fujiwara, David S. Hong

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    A crisis in clinical research

    A crisis in clinical research oleh Mario Sznol, Patricia LoRusso, David S Hong

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service.

    Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. oleh Henrique A Parsons, Vickie E Baracos, Navjot Dhillon, David S Hong, Razelle Kurzrock

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Burden of influenza hospitalization among high-risk groups in the United States

    Burden of influenza hospitalization among high-risk groups in the United States oleh Aimee M. Near, Jenny Tse, Yinong Young-Xu, David K. Hong, Carolina M. Reyes

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

    TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma oleh Matthew J. Reilley, Brittany Morrow, Casey R. Ager, Arthur Liu, David S. Hong, Michael A. Curran

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

    Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab oleh Siqing Fu, Sang T. Kim, Jean Tayar, David S. Hong, Elliot Norry, Amy Sun, Danxia Ke, Juli Miller

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

    Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study oleh Kalevi Kairemo, Elmer B. Santos, Homer A. Macapinlac, Shreyaskumar Patel, Anthony P. Conley, David S. Hong, Vivek Subbiah

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Student Preferences on Gaming Aspects for a Serious Game in Pharmacy Practice Education: A Cross-Sectional Study

    Student Preferences on Gaming Aspects for a Serious Game in Pharmacy Practice Education: A Cross-Sectional Study oleh Chang, Huan Ying, Poh, David Yan Hong, Wong, Li Lian, Yap, John Yin Gwee, Yap, Kevin Yi-Lwern

    Diterbitkan 2015-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    The robust and rapid role of molecular testing in precision fungal diagnostics: A case report

    The robust and rapid role of molecular testing in precision fungal diagnostics: A case report oleh Julie M. Steinbrink, David K. Hong, Stephen P. Bergin, Rami N. Al-Rohil, John R. Perfect, Eileen K. Maziarz

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy

    Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy oleh Joseph D. Butner, Prashant Dogra, Caroline Chung, Eugene J. Koay, James W. Welsh, David S. Hong, Vittorio Cristini, Zhihui Wang

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose

    Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose oleh Wenyuan Xiong, Manja Friese‐Hamim, Andreas Johne, Christopher Stroh, Manfred Klevesath, Gerald S. Falchook, David S. Hong, Pascal Girard, Samer El Bawab

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Rapid detection of invasive Mycobacterium chimaera disease via a novel plasma-based next-generation sequencing test

    Rapid detection of invasive Mycobacterium chimaera disease via a novel plasma-based next-generation sequencing test oleh Jim Nomura, Gunter Rieg, Gary Bluestone, Townson Tsai, Andrew Lai, Dawn Terashita, Sivan Bercovici, David K. Hong, Brian P. Lee

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

    PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. oleh Filip Janku, J Jack Lee, Apostolia M Tsimberidou, David S Hong, Aung Naing, Gerald S Falchook, Siqing Fu, Rajyalakshmi Luthra, Ignacio Garrido-Laguna, Razelle Kurzrock

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.

    KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. oleh Ignacio Garrido-Laguna, David S Hong, Filip Janku, Ly M Nguyen, Gerald S Falchook, Siqing Fu, Jenifer J Wheler, Rajyalakshmi Luthra, Aung Naing, Xuemei Wang, Razelle Kurzrock

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    An ex vivo model of Toxoplasma recrudescence reveals developmental plasticity of the bradyzoite stage

    An ex vivo model of Toxoplasma recrudescence reveals developmental plasticity of the bradyzoite stage oleh Edward A. Vizcarra, Amber L. Goerner, Arzu Ulu, David D. Hong, Kristina V. Bergersen, Michael A. Talavera, Karine Le Roch, Emma H. Wilson, Michael W. White

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Molecular characterization of breast cancer CTCs associated with brain metastasis

    Molecular characterization of breast cancer CTCs associated with brain metastasis oleh Debasish Boral, Monika Vishnoi, Haowen N. Liu, Wei Yin, Marc L. Sprouse, Antonio Scamardo, David S. Hong, Tuan Z. Tan, Jean P. Thiery, Jenny C. Chang, Dario Marchetti

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Neuromonitoring-guided working memory intervention in children with ADHD

    Neuromonitoring-guided working memory intervention in children with ADHD oleh Ali Rahimpour Jounghani, Elveda Gozdas, Lauren Dacorro, Bárbara Avelar-Pereira, Samantha Reitmaier, Hannah Fingerhut, David S. Hong, Glen Elliott, Antonio Y. Hardan, Stephen P. Hinshaw, S.M. Hadi Hosseini

    Diterbitkan 2024-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data

    Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data oleh Ji Son, Rodney Cheng-En Hsieh, Rodney Cheng-En Hsieh, Heather Y. Lin, Kate J. Krause, Ying Yuan, Amadeo B. Biter, James Welsh, Michael A. Curran, David S. Hong

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies

    Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies oleh Wei Li, James Welsh, Vivek Verma, David S Hong, Nathan I Comeaux, Joe Y Chang, Jordi Rodon Ahnert, Daniel D Karp, Ecaterina E Dumbrava, Xinyan Xu, Girish S Shroff, Aileen Chen

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: